Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 535

1.

Impact of epidural analgesia on the systemic biomarker response after hepatic resection.

Vicente D, Patino M, Marcus R, Lillmoe H, Limani P, Newhook T, Lee A, Tzeng CW, Segraves-Chun Y, Tweardy D, Gottumukkala V, Vauthey JN, Aloia T, Cata JP.

Oncotarget. 2019 Jan 15;10(5):584-594. doi: 10.18632/oncotarget.26549. eCollection 2019 Jan 15.

2.

Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors.

Vega EA, Vinuela E, Okuno M, Joechle K, Sanhueza M, Diaz C, Jarufe N, Martinez J, Troncoso A, Diaz A, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C.

HPB (Oxford). 2019 Jan 30. pii: S1365-182X(19)30008-5. doi: 10.1016/j.hpb.2018.12.006. [Epub ahead of print]

PMID:
30711243
3.

Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator.

Vega EA, Vinuela E, Sanhueza M, Mege R, Caracci M, Diaz C, Diaz A, Okuno M, Joechle K, Goumard C, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C.

Eur J Surg Oncol. 2019 Jan 24. pii: S0748-7983(19)30036-8. doi: 10.1016/j.ejso.2019.01.013. [Epub ahead of print]

PMID:
30704808
4.

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer.

Varkaris A, Katsiampoura A, Davis JS, Shah N, Lam M, Frias RL, Ivan C, Shimizu M, Morris J, Menter D, Overman M, Tran H, Heymach J, Chun YS, Vauthey JN, Calin G, Kopetz S.

Br J Cancer. 2019 Feb;120(3):340-345. doi: 10.1038/s41416-018-0360-y. Epub 2019 Jan 14.

PMID:
30636774
5.

Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases.

Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Vauthey JN, Mehran RJ.

J Thorac Cardiovasc Surg. 2018 Nov 26. pii: S0022-5223(18)33149-0. doi: 10.1016/j.jtcvs.2018.10.156. [Epub ahead of print]

PMID:
30635188
6.

Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis.

Cloyd JM, Chen HC, Wang X, Tzeng CD, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG.

Pancreas. 2019 Feb;48(2):216-222. doi: 10.1097/MPA.0000000000001231.

PMID:
30629022
7.

Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma.

Kim BJ, Prakash L, Narula N, Davis CH, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH, Tzeng CD.

HPB (Oxford). 2018 Dec 3. pii: S1365-182X(18)34506-4. doi: 10.1016/j.hpb.2018.10.009. [Epub ahead of print]

PMID:
30522947
8.

Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma.

Simoneau E, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Kim MP, Katz MHG, Tzeng CD.

Ann Surg Oncol. 2019 Feb;26(2):652. doi: 10.1245/s10434-018-07093-x. Epub 2018 Dec 11.

PMID:
30539487
9.

Preoperative drainage for perihilar cholangiocarcinoma.

Odisio BC, Krampitz GW, Murthy R, Mahvash A, Javle M, Vauthey JN.

Lancet Gastroenterol Hepatol. 2019 Jan;4(1):10-11. doi: 10.1016/S2468-1253(18)30345-5. Epub 2018 Dec 6. No abstract available.

PMID:
30527574
10.

Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization.

Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CD.

HPB (Oxford). 2018 Nov 27. pii: S1365-182X(18)34525-8. doi: 10.1016/j.hpb.2018.10.018. [Epub ahead of print]

PMID:
30501986
11.

Clinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After Pancreatectomy.

Newhook TE, Vreeland TJ, Dewhurst WL, Wang X, Prakash L, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CD.

Ann Surg. 2018 Nov 29. doi: 10.1097/SLA.0000000000003112. [Epub ahead of print]

PMID:
30499795
12.

Middle Hepatic Vein Roadmap for a Safe Laparoscopic Right Hepatectomy.

Joechle K, Vega EA, Okuno M, Simoneau E, Ogiso S, Newhook TE, Ramirez DL, Holmes AA, Soliz JM, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C.

Ann Surg Oncol. 2019 Jan;26(1):296. doi: 10.1245/s10434-018-7034-0. Epub 2018 Nov 21.

PMID:
30465224
13.

ASO Author Reflections: RAS Mutations in Metastatic Colorectal Cancer.

Passot G, Vauthey JN, Chun YS.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):850-851. doi: 10.1245/s10434-018-7020-6. Epub 2018 Nov 12. No abstract available.

PMID:
30421059
14.

Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases.

Lee AJ, Loyer EM, Kang HC, Aloia TA, Tzeng CD, Vauthey JN, Chun YS.

Ann Surg Oncol. 2019 Jan;26(1):275-281. doi: 10.1245/s10434-018-6945-0. Epub 2018 Oct 25.

PMID:
30362064
15.

Comprehensive Complication Index Validates Improved Outcomes Over Time Despite Increased Complexity in 3707 Consecutive Hepatectomies.

Cloyd JM, Mizuno T, Kawaguchi Y, Lillemoe HA, Karagkounis G, Omichi K, Chun YS, Conrad C, Tzeng CD, Odisio BC, Huang SY, Hicks M, Wei SH, Aloia TA, Vauthey JN.

Ann Surg. 2018 Oct 17. doi: 10.1097/SLA.0000000000003043. [Epub ahead of print]

PMID:
30339628
16.

ASO Author Reflections: Role of Preoperative Chemotherapy in the Treatment of Pancreatic Neuroendocrine Liver Metastases.

Tran Cao HS, Vauthey JN.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):792-793. doi: 10.1245/s10434-018-6921-8. Epub 2018 Oct 17. No abstract available.

PMID:
30334195
17.

The Prognostic Impact of KRAS Mutation in Patients Having Curative Resection of Synchronous Colorectal Liver Metastases.

Goffredo P, Utria AF, Beck AC, Chun YS, Howe JR, Weigel RJ, Vauthey JN, Hassan I.

J Gastrointest Surg. 2018 Oct 1. doi: 10.1007/s11605-018-3978-4. [Epub ahead of print]

PMID:
30276588
18.

Conceptual framework of middle hepatic vein anatomy as a roadmap for safe right hepatectomy.

Ogiso S, Okuno M, Shindoh J, Sakamoto Y, Mizuno T, Araki K, Goumard C, Nomi T, Ishii T, Uemoto S, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C.

HPB (Oxford). 2019 Jan;21(1):43-50. doi: 10.1016/j.hpb.2018.01.002. Epub 2018 Sep 25.

PMID:
30266496
19.

The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma.

Cloyd JM, Prakash L, Vauthey JN, Aloia TA, Chun YS, Tzeng CW, Kim MP, Lee JE, Katz MHG.

Am J Surg. 2018 Sep 6. pii: S0002-9610(18)30811-0. doi: 10.1016/j.amjsurg.2018.08.024. [Epub ahead of print]

PMID:
30224070
20.

Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases.

Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Aloia TA, Conrad C.

Surgery. 2019 Feb;165(2):329-336. doi: 10.1016/j.surg.2018.07.031. Epub 2018 Sep 6.

PMID:
30197278

Supplemental Content

Loading ...
Support Center